Background This study aimed toinvestigate the association between clinical and laboratory parameters andresponse to therapy with sodium-glucose cotransporter 2 inhibitors (SGLT2i) inpatients with type 2 diabetes mellitus (T2D).
No takes yet. Share an insight, caveat, or question.
Pitsiava et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: